slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 1,441-1,470
Pages 885
Rows per page 30
Arc
1,441-1,470 of 26,550
05
Uses a Venn-style diagram to illustrate the small overlap between screening and successful drug candidates.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · Problem2 hits
06
The diagram uses a Venn-like overlap to visually represent the expansion of 'right sequences' explored.Absci | Investor Presentation Deck | 30 slides · Absci
Pitch deck Investor relations Beat · AgitateLoop · Jobs To Be Done2 hits
06
Includes a photo of a child with medical equipment to humanize the disease impact.Albireo Pharma | Results Presentation Deck | 18 slides · Albireo Pharma
Conference presentation Investor relations Beat · Problem2 hits
05
Aldeyra Therapeutics | Results Presentation Deck | 13 slidesAldeyra Therapeutics | Results Presentation Deck | 13 slides · Aldeyra Therapeutics
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
05
Uses a before-after framing to contrast traditional 'one-size-fits-all' medicine with personalized medicine.Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · ProblemLoop · Before After2 hits
10
The slide demonstrates the predictive power of the DRP biomarker by contrasting the entire study population (no benefit) with the DRP-selected subgroup (significant benefit).Allarity Therapeutics | Investor Conference Presentation Deck | 23 slides · Allarity Therapeutics
Conference presentation Investor relations Beat · AgitateLoop · Before After2 hits
10
The chart uses a stacked bar approach to show captured vs. estimated visits, with trend lines indicating growth rates.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
11
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
12
The slide uses a circular infographic layout to connect a visual of cannabis products to three distinct risk categories.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
04
The slide uses callout boxes connected to specific organs to detail symptom frequency and clinical manifestations.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Agitate (Make it worse)2 hits
05
The chart uses a dual-line comparison to show the divergence in risk outcomes based on treatment timing.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
05
Uses a two-column layout to contrast 'Significant Burden' with 'Urgent Need for Innovation'.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
06
The slide uses a Gantt-style visualization to represent clinical trial progress for various drug candidates.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · AgitationLoop · Cost Of Inaction2 hits
07
The slide uses a horizontal arrow timeline to organize clinical trial phases and results.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · AgitationLoop · Cost Of Inaction2 hits
10
ATAI | Investor Presentation Deck | 41 slidesATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
11
The slide uses chemical structure diagrams to illustrate the relationship between the racemate and its enantiomers.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
12
Data source: Zanos et al., 2016. The charts show dose-dependent reduction in immobility time.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
06
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction2 hits
06
The slide combines a bar chart for revenue projections and a segmented pie/fan chart for patient population sizing.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
07
The slide uses a checkmark/cross matrix to highlight the competitive advantage of BNC210.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction2 hits
11
Includes two charts: a bar chart for SVR achievement and a waterfall plot for median percentage change in spleen volume.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
12
Includes a bar chart for response rates and a waterfall plot for individual patient symptom changes.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
13
The slide uses three bar charts to illustrate clinical efficacy endpoints related to anemia in a specific patient population.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
09
The slide uses stacked bar charts to compare response rates (Complete, Partial, No Response) at different time intervals for two drugs.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
10
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction2 hits
07
The slide uses a circular process flow to represent a continuous improvement or learning loop in pharmaceutical R&D.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication2 hits
08
The slide uses a process flow diagram to link preclinical models to the drug development pipeline.Exscientia | Results Presentation Deck | 33 slides · Exscientia
Conference presentation Investor relations Beat · Complication2 hits
04
The slide outlines a financial challenge (funding gap) and specific operational strategies to address it.SkyHarbour | Investor Presentation Deck | 8 slides · SkyHarbour
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction2 hits
12
The slide uses a central human anatomy diagram to map specific cancer types to their respective mesothelin expression rates.TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits
15
The slide uses a process diagram to illustrate the dose escalation cohorts leading to the Recommended Phase 2 Dose (RP2D).TCR2 Therapeutics | Results Presentation Deck | 34 slides · TCR2 Therapeutics
Regulatory filing Investor relations Beat · SolutionLoop · Jobs To Be Done2 hits